Status:
UNKNOWN
Efficacy of Tranexamic Acid in Upper Gastrointestinal Bleeding
Lead Sponsor:
Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions:
Gastro Intestinal Bleeding
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Upper Gastrointestinal bleed is a common presentation in a medical emergency. Patients generally present with hematemesis, melena or in severe cases hematochezia. Incidence and etiology vary from regi...
Eligibility Criteria
Inclusion
- Irrespective of gender and with age ≥ 18 years, all the patients presenting with symptoms of acute UGI bleed will be enrolled for the study after taking written informed consent.
Exclusion
- Patients with UGI bleed for more than 48 hours, history of UGI bleed in previous 1 year
- Chronic kidney disease
- Pregnancy and breast feeding
- Malignancy
- Patients who have already received TXA
- UGI endoscopy done beyond 24 hours of admission because of hemodynamic instability or encephalopathy
- Patients who will be receiving blood thinners like anti-platelets, anti-coagulation agents within 4 weeks of presentation
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04788121
Start Date
November 1 2020
End Date
June 30 2021
Last Update
March 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Post Graduate Institute of Medical Education and Research
Chandigarh, India, 160012